美好医疗
(301363)
| 流通市值：26.95亿 | | | 总市值：98.13亿 |
| 流通股本：1.56亿 | | | 总股本：5.69亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 295,757,022.22 | 1,594,208,109.7 | 1,156,571,221.99 | 706,449,459.94 |
| 营业收入 | 295,757,022.22 | 1,594,208,109.7 | 1,156,571,221.99 | 706,449,459.94 |
| 二、营业总成本 | 246,494,069.6 | 1,183,768,717.99 | 878,898,846.47 | 514,255,774.5 |
| 营业成本 | 179,578,329.48 | 923,398,502.6 | 673,298,597.6 | 416,585,011.8 |
| 税金及附加 | 3,928,808.21 | 15,827,532.65 | 10,661,892.44 | 6,238,196.45 |
| 销售费用 | 12,011,007.5 | 45,127,500.29 | 30,315,989.59 | 15,941,959.55 |
| 管理费用 | 31,278,719.84 | 107,766,951.8 | 74,753,349.52 | 43,160,815.94 |
| 研发费用 | 32,674,593.72 | 140,575,368.64 | 103,341,218.61 | 57,386,444.88 |
| 财务费用 | -12,977,389.15 | -48,927,137.99 | -13,472,201.29 | -25,056,654.12 |
| 其中:利息收入 | 9,639,020.76 | 42,677,719.14 | 30,727,362.44 | 19,425,840.98 |
| 加:公允价值变动收益 | 717,117.01 | 837,654.74 | 304,900.26 | 433,913.74 |
| 加:投资收益 | 1,560,436.03 | 10,052,933.69 | 6,526,682.47 | 4,803,118.37 |
| 资产处置收益 | 15.58 | -279,865.63 | -280,245.31 | -323,527.84 |
| 资产减值损失(新) | -1,298,329.15 | -13,816,908.61 | -2,782,594.76 | -797,022.35 |
| 信用减值损失(新) | 4,540,302.77 | -7,462,009.88 | -1,802,546.35 | -4,336,081.26 |
| 其他收益 | 1,931,018.09 | 10,711,233.32 | 9,682,528.7 | 4,437,689.18 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 56,713,512.95 | 410,482,429.34 | 289,321,100.53 | 196,411,775.28 |
| 加:营业外收入 | 112,715.3 | 5,567.56 | 4,265.56 | 2,905.13 |
| 减:营业外支出 | 6,799.04 | 235,889.44 | 99,501.41 | 94,553.17 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 56,819,429.21 | 410,252,107.46 | 289,225,864.68 | 196,320,127.24 |
| 减:所得税费用 | 4,944,435.59 | 46,475,630.04 | 31,376,652.86 | 27,144,782.11 |
| 六、净利润 | 51,874,993.62 | 363,776,477.42 | 257,849,211.82 | 169,175,345.13 |
| 持续经营净利润 | 51,874,993.62 | 363,776,477.42 | 257,849,211.82 | 169,175,345.13 |
| 归属于母公司股东的净利润 | 51,874,993.62 | 363,776,477.42 | 257,849,211.82 | 169,175,345.13 |
| (一)基本每股收益 | 0.13 | 0.9 | 0.64 | 0.42 |
| (二)稀释每股收益 | 0.13 | 0.9 | 0.64 | 0.42 |
| 八、其他综合收益 | -1,581,975.66 | 21,402,594.46 | 38,949,424.1 | -6,280,786.77 |
| 归属于母公司股东的其他综合收益 | -1,581,975.66 | 21,402,594.46 | 38,949,424.1 | -6,280,786.77 |
| 九、综合收益总额 | 50,293,017.96 | 385,179,071.88 | 296,798,635.92 | 162,894,558.36 |
| 归属于母公司股东的综合收益总额 | 50,293,017.96 | 385,179,071.88 | 296,798,635.92 | 162,894,558.36 |
| 公告日期 | 2025-04-25 | 2025-04-18 | 2024-10-25 | 2024-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |